Published in Br J Psychiatry on March 22, 2012
Amisulpride versus other atypical antipsychotics for schizophrenia. Cochrane Database Syst Rev (2010) 0.98
Spontaneous parkinsonism is associated with cognitive impairment in antipsychotic-naive patients with first-episode psychosis: a 6-month follow-up study. Schizophr Bull (2013) 0.91
Is schizophrenia a dopamine supersensitivity psychotic reaction? Prog Neuropsychopharmacol Biol Psychiatry (2013) 0.85
Second-generation antipsychotics and extrapyramidal adverse effects. Biomed Res Int (2014) 0.84
In Vitro and In Vivo Characterization of the Alkaloid Nuciferine. PLoS One (2016) 0.82
Role for the nicotinic cholinergic system in movement disorders; therapeutic implications. Pharmacol Ther (2014) 0.82
Neurochemical Metabolomics Reveals Disruption to Sphingolipid Metabolism Following Chronic Haloperidol Administration. J Neuroimmune Pharmacol (2015) 0.80
Movement disorders in elderly users of risperidone and first generation antipsychotic agents: a Canadian population-based study. PLoS One (2013) 0.78
Haloperidol-induced striatal Nur77 expression in a non-human primate model of tardive dyskinesia. Eur J Neurosci (2013) 0.78
Lack of tolerable treatment options for patients with schizophrenia. Neuropsychiatr Dis Treat (2015) 0.77
Extrapyramidal side-effects and antipsychotics: are second-generation agents still indicated? Br J Psychiatry (2012) 0.75
Striatal cholinergic interneurons and D2 receptor-expressing GABAergic medium spiny neurons regulate tardive dyskinesia. Exp Neurol (2016) 0.75
Effectiveness evaluation of a pharmacist-driven monitoring database for tardive dyskinesia. Hosp Pharm (2014) 0.75
Binding of Sulpiride to Seric Albumins. Int J Mol Sci (2016) 0.75
First-generation antipsychotics: not gone but forgotten. BJPsych Bull (2016) 0.75
Tardive dyskinesia in a South Asian population with first episode psychosis treated with antipsychotics. Neuropsychiatr Dis Treat (2014) 0.75
No difference in extrapyramidal side effects between first-generation and second-generation antipsychotics. Evid Based Ment Health (2012) 0.75
Gingival pain: an unusual side effect of ziprasidone. BMJ Case Rep (2013) 0.75
Extrapyramidal side effects of antipsychotics are linked to their association kinetics at dopamine D2 receptors. Nat Commun (2017) 0.75
Incidence and risk factors of acute akathisia in 493 individuals with first episode non-affective psychosis: a 6-week randomised study of antipsychotic treatment. Psychopharmacology (Berl) (2017) 0.75
Real-world risk of diabetes with antipsychotic use in older New Zealanders: a case-crossover study. Eur J Clin Pharmacol (2016) 0.75
Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet (2007) 11.27
Randomized controlled trial of the effect on Quality of Life of second- vs first-generation antipsychotic drugs in schizophrenia: Cost Utility of the Latest Antipsychotic Drugs in Schizophrenia Study (CUtLASS 1). Arch Gen Psychiatry (2006) 9.44
Oligodendrocyte dysfunction in schizophrenia and bipolar disorder. Lancet (2003) 4.84
Cognitive therapy for the prevention of psychosis in people at ultra-high risk: randomised controlled trial. Br J Psychiatry (2004) 4.74
Obstetric complications and schizophrenia: historical and meta-analytic review. Am J Psychiatry (2002) 4.03
Why psychiatry can't afford to be neurophobic. Br J Psychiatry (2009) 3.80
Heterogeneity in incidence rates of schizophrenia and other psychotic syndromes: findings from the 3-center AeSOP study. Arch Gen Psychiatry (2006) 3.35
Relapse prevention in schizophrenia with new-generation antipsychotics: a systematic review and exploratory meta-analysis of randomized, controlled trials. Am J Psychiatry (2003) 3.18
Incidence of schizophrenia and other psychoses in ethnic minority groups: results from the MRC AESOP Study. Psychol Med (2006) 2.79
Randomized controlled trial of effect of prescription of clozapine versus other second-generation antipsychotic drugs in resistant schizophrenia. Schizophr Bull (2006) 2.71
Early detection and intervention evaluation for people at risk of psychosis: multisite randomised controlled trial. BMJ (2012) 2.70
The use of psychotropic medication in patients with emotionally unstable personality disorder under the care of UK mental health services. J Clin Psychiatry (2015) 2.67
Outcomes of conduct problems in adolescence: 40 year follow-up of national cohort. BMJ (2009) 2.47
Disease-relevant autoantibodies in first episode schizophrenia. J Neurol (2010) 2.33
Incidence of schizophrenia and other psychoses in England, 1950-2009: a systematic review and meta-analyses. PLoS One (2012) 2.33
Cannabis and schizophrenia: model projections of the impact of the rise in cannabis use on historical and future trends in schizophrenia in England and Wales. Addiction (2007) 2.20
Psychotic experiences and psychotic disorders at age 18 in relation to psychotic experiences at age 12 in a longitudinal population-based cohort study. Am J Psychiatry (2013) 2.17
Group art therapy as an adjunctive treatment for people with schizophrenia: multicentre pragmatic randomised trial. BMJ (2012) 2.17
Schizophrenia in the offspring of antenatally depressed mothers in the northern Finland 1966 birth cohort: relationship to family history of psychosis. Am J Psychiatry (2009) 2.11
A quantitative meta-analysis of population-based studies of premorbid intelligence and schizophrenia. Schizophr Res (2011) 2.09
Cross-national clinical and functional remission rates: Worldwide Schizophrenia Outpatient Health Outcomes (W-SOHO) study. Br J Psychiatry (2011) 2.06
Raised incidence rates of all psychoses among migrant groups: findings from the East London first episode psychosis study. Arch Gen Psychiatry (2008) 1.96
Reliability and comparability of psychosis patients' retrospective reports of childhood abuse. Schizophr Bull (2009) 1.94
Increased pituitary volume in antipsychotic-free and antipsychotic-treated patients of the AEsop first-onset psychosis study. Neuropsychopharmacology (2005) 1.76
Three-year follow-up of a randomized controlled trial of cognitive therapy for the prevention of psychosis in people at ultrahigh risk. Schizophr Bull (2006) 1.73
Self-harm in first-episode psychosis. Br J Psychiatry (2008) 1.72
Substance use in a population-based clinic sample of people with first-episode psychosis. Br J Psychiatry (2007) 1.71
Infant developmental milestones and subsequent cognitive function. Ann Neurol (2007) 1.69
ROAMER: roadmap for mental health research in Europe. Int J Methods Psychiatr Res (2014) 1.67
Developmental typology of trajectories to nighttime bladder control: epidemiologic application of longitudinal latent class analysis. Am J Epidemiol (2003) 1.65
The feasibility and validity of ambulatory self-report of psychotic symptoms using a smartphone software application. BMC Psychiatry (2012) 1.58
Insight as a predictor of the outcome of first-episode nonaffective psychosis in a prospective cohort study in England. J Clin Psychiatry (2007) 1.56
Starting dose is a risk factor for allopurinol hypersensitivity syndrome: a proposed safe starting dose of allopurinol. Arthritis Rheum (2012) 1.54
Childhood cognitive ability and adult mental health in the British 1946 birth cohort. Soc Sci Med (2007) 1.54
Forty-year psychiatric outcomes following assessment for internalizing disorder in adolescence. Am J Psychiatry (2007) 1.54
Effects of cannabis use on outcomes of psychotic disorders: systematic review. Br J Psychiatry (2008) 1.53
A longitudinal typology of symptoms of depression and anxiety over the life course. Biol Psychiatry (2007) 1.47
Childhood infection and adult schizophrenia: a meta-analysis of population-based studies. Schizophr Res (2012) 1.46
Gender differences in incidence and age at onset of mania and bipolar disorder over a 35-year period in Camberwell, England. Am J Psychiatry (2005) 1.42
Cannabis use and outcome of recent onset psychosis. Eur Psychiatry (2005) 1.42
Recovery from schizophrenic psychoses within the northern Finland 1966 Birth Cohort. J Clin Psychiatry (2005) 1.42
Discrimination learning, reversal, and set-shifting in first-episode schizophrenia: stability over six years and specific associations with medication type and disorganization syndrome. Biol Psychiatry (2009) 1.41
Neighbourhood-level effects on psychoses: re-examining the role of context. Psychol Med (2007) 1.38
Cohort profile: risk patterns and processes for psychopathology emerging during adolescence: the ROOTS project. Int J Epidemiol (2009) 1.37
The structural brain correlates of neurological soft signs in AESOP first-episode psychoses study. Brain (2003) 1.35
Different effects of typical and atypical antipsychotics on grey matter in first episode psychosis: the AESOP study. Neuropsychopharmacology (2005) 1.32
Association of variation in Fcgamma receptor 3B gene copy number with rheumatoid arthritis in Caucasian samples. Ann Rheum Dis (2010) 1.31
Gender differences in the association between childhood abuse and psychosis. Br J Psychiatry (2009) 1.30
Integrating mobile-phone based assessment for psychosis into people's everyday lives and clinical care: a qualitative study. BMC Psychiatry (2013) 1.25
Functional dysconnectivity of corticostriatal circuitry as a risk phenotype for psychosis. JAMA Psychiatry (2013) 1.25
Duration of untreated psychosis and its relationship to clinical outcome. Br J Psychiatry Suppl (2005) 1.24
Gene expression analysis in schizophrenia: reproducible up-regulation of several members of the apolipoprotein L family located in a high-susceptibility locus for schizophrenia on chromosome 22. Proc Natl Acad Sci U S A (2002) 1.22
Abnormal brain connectivity in first-episode psychosis: a diffusion MRI tractography study of the corpus callosum. Neuroimage (2006) 1.20
Gender-specific effects of the catechol-O-methyltransferase Val108/158Met polymorphism on cognitive function in children. Am J Psychiatry (2007) 1.20
Specific and generalized neuropsychological deficits: a comparison of patients with various first-episode psychosis presentations. Am J Psychiatry (2009) 1.20
White matter tracts in first-episode psychosis: a DTI tractography study of the uncinate fasciculus. Neuroimage (2007) 1.18
Social deprivation, inequality, and the neighborhood-level incidence of psychotic syndromes in East London. Schizophr Bull (2012) 1.17
Reasons for the diagnostic discordance between clinicians and researchers in schizophrenia in the Northern Finland 1966 Birth Cohort. Soc Psychiatry Psychiatr Epidemiol (2003) 1.16
Profiles of family-focused adverse experiences through childhood and early adolescence: the ROOTS project a community investigation of adolescent mental health. BMC Psychiatry (2011) 1.15
Predictors of schizophrenia--a review. Br Med Bull (2005) 1.15
Cognitive heterogeneity in first-episode schizophrenia. Br J Psychiatry (2005) 1.11
Mokken scale analysis of mental health and well-being questionnaire item responses: a non-parametric IRT method in empirical research for applied health researchers. BMC Med Res Methodol (2012) 1.11
A randomized controlled trial of cognitive-behavior therapy for persistent symptoms in schizophrenia: a five-year follow-up. Schizophr Res (2007) 1.08
Visuospatial learning and executive function are independently impaired in first-episode psychosis. Psychol Med (2005) 1.08
Fronto-cerebellar systems are associated with infant motor and adult executive functions in healthy adults but not in schizophrenia. Proc Natl Acad Sci U S A (2006) 1.08
The renal urate transporter SLC17A1 locus: confirmation of association with gout. Arthritis Res Ther (2012) 1.08
Gray matter abnormalities associated with duration of untreated psychosis. Schizophr Res (2006) 1.07
Correction: Therapist Effects and the Impact of Early Therapeutic Alliance on Symptomatic Outcome in Chronic Fatigue Syndrome. PLoS One (2016) 1.07
Elevated morning cortisol is a stratified population-level biomarker for major depression in boys only with high depressive symptoms. Proc Natl Acad Sci U S A (2014) 1.07
Prevalence of depression in older people in England and Wales: the MRC CFA Study. Psychol Med (2007) 1.06
Acute and transient psychotic disorders: precursors, epidemiology, course and outcome. Br J Psychiatry (2004) 1.06
Role of the prescribing observatory for mental health. Br J Psychiatry (2012) 1.05
The persistence of developmental markers in childhood and adolescence and risk for schizophrenic psychoses in adult life. A 34-year follow-up of the Northern Finland 1966 birth cohort. Schizophr Res (2004) 1.05
Effects of catechol-O-methyltransferase on normal variation in the cognitive function of children. Am J Psychiatry (2009) 1.05
The prevention of schizophrenia--what can we learn from eco-epidemiology? Schizophr Bull (2010) 1.02
Incentive motivation in first-episode psychosis: a behavioural study. BMC Psychiatry (2008) 1.01
The acceptability of routine inquiry about domestic violence towards women: a survey in three healthcare settings. Br J Gen Pract (2006) 1.01
High-dose and combination antipsychotic prescribing in acute adult wards in the UK: the challenges posed by p.r.n. prescribing. Br J Psychiatry (2008) 1.01
The relationship between antisaccades, smooth pursuit, and executive dysfunction in first-episode schizophrenia. Biol Psychiatry (2004) 1.00
The structural brain correlates of neurological soft signs in healthy individuals. Cereb Cortex (2005) 1.00
Neighbourhood variation in the incidence of psychotic disorders in Southeast London. Soc Psychiatry Psychiatr Epidemiol (2007) 1.00
Intrinsic curvature: a marker of millimeter-scale tangential cortico-cortical connectivity? Int J Neural Syst (2011) 1.00
Morphometric brain abnormalities in schizophrenia in a population-based sample: relationship to duration of illness. Schizophr Bull (2008) 0.99
How to compare doses of different antipsychotics: a systematic review of methods. Schizophr Res (2013) 0.99
Association of cannabis use with prodromal symptoms of psychosis in adolescence. Br J Psychiatry (2008) 0.99
Expressed emotion: relevance to rehospitalization in schizophrenia over 7 years. Schizophr Bull (2005) 0.99
IQ as a predictor of functional outcome in schizophrenia: a longitudinal, four-year study of first-episode psychosis. Schizophr Res (2008) 0.99
The effect of cannabis use and cognitive reserve on age at onset and psychosis outcomes in first-episode schizophrenia. Schizophr Bull (2011) 0.97
Cohort profile: mental health following extreme trauma in a northern Ugandan cohort of War-Affected Youth Study (The WAYS Study). Springerplus (2013) 0.97
A window into the brain: an in vivo study of the retina in schizophrenia using optical coherence tomography. Psychiatry Res (2012) 0.96
The relationship between IQ, memory, executive function, and processing speed in recent-onset psychosis: 1-year stability and clinical outcome. Schizophr Bull (2008) 0.96
Early detection and intervention evaluation for people at high-risk of psychosis-2 (EDIE-2): trial rationale, design and baseline characteristics. Early Interv Psychiatry (2011) 0.95
Evaluation of akathisia in patients with schizophrenia, schizoaffective disorder, or bipolar I disorder: a post hoc analysis of pooled data from short- and long-term aripiprazole trials. J Psychopharmacol (2009) 0.95